Denka Company Limited (4061) Stock Price

Denka Corporation is a corporate group consisting of 60 subsidiaries and 20 affiliated companies, operating primarily across four business segments: "Electronics & Advanced Products," "Life Innovation," "Elastomer & Infrastructure Solutions," and "Polymer Solutions."

The "Electronics & Advanced Products" segment manufactures and sells fused silica, spherical alumina, electronic circuit boards, and fine ceramics. The company operates manufacturing and sales facilities both domestically and internationally, with active operations in Singapore, China, Vietnam, and other regions.

The "Life Innovation" segment handles vaccines, antigen rapid diagnostic kits, and cancer treatment viral agents. In addition to domestic manufacturing and sales, the company also conducts research and development in Germany and Singapore.

The "Elastomer & Infrastructure Solutions" segment provides chloroprene rubber, fertilizers, and refractory materials. Manufacturing and sales operations are conducted in the United States, China, and Southeast Asia, with particular focus on chloroprene rubber production.

The "Polymer Solutions" segment manufactures and sells styrene monomer, ABS resin, and food packaging sheets. The company operates both domestically and internationally, with notable styrene-based resin manufacturing in Singapore.

The company also operates other businesses including plant engineering, wholesale distribution, and power supply operations. Subsidiaries and affiliated companies such as Denka Engineering, YK Across, and Kurobe River Electric manage these operations.

Denka Corporation has been implementing its medium-term management plan "Mission 2030" since fiscal year 2023. This plan pursues three growth strategies—"Business Value Creation," "Human Capital Value Creation," and "Management Value Creation"—to enhance corporate value. In particular, the company is focusing on three priority domains: ICT & Energy, Healthcare, and Sustainable Living, with the goal of developing these into "three-star businesses" by 2030.

As part of business value creation, Denka is advancing portfolio reform. In response to structural challenges in its chloroprene rubber business, the company has temporarily suspended manufacturing operations at Denka Performance Elastomers, its U.S. manufacturing subsidiary, and is exploring possibilities for business transfer or asset divestiture. Additionally, Denka has decided to halt operations at its Ofuna plant and is consolidating its synthetic fiber wig yarn business "Toyokalon®" in Singapore as part of its structural reforms.

Furthermore, Denka is reviewing its investment plan with the goal of reducing capital expenditures by 10 billion yen. The company is concentrating management resources on critical investment projects while maintaining investment in growth-essential fields. Notably, in the ICT & Energy domain, Denka is expanding production capacity for next-generation high-performance spherical fillers and silicon nitride.

Denka is driving a company-wide cost reduction project and achieved approximately 1.3 billion yen in cost savings in fiscal year 2024. The company aims to achieve 10 billion yen in cost reductions by fiscal year 2026 and continues to pursue operational efficiency. Through these initiatives, Denka is working to return to a growth trajectory in its business performance.